Most animals, including humans, have a high avidity for consuming dietary fat. Previous studies have reported that fat preference can be attributed to many factors, including palatable flavor, texture, and chemical perception. Moreover, transection of nerves associated with either olfaction or gustation (i.e., olfactory or glossopharyngeal nerve) has been shown to decrease fat ingestion (1-3). In the central nervous system, several studies have suggested that the opioid system, canonically associated with reward circuitry, is associated with dietary preferences for fat. We recently reported that fat ingestion induces elevations in the endogenous opioid peptide, beta-endorphin, in cerebrospinal fluid (4). Furthermore, we have also demonstrated that fat ingestion can activate pro-opiomelanocortin (POMC) neurons in the hypothalamus, which synthesize beta-endorphin (5). Many reports have suggested that administration of opioid receptor antagonists can attenuate fat preference, an observation that is consistent with our findings (4, (6) (7) (8) .
Most animals, including humans, have a high avidity for consuming dietary fat. Previous studies have reported that fat preference can be attributed to many factors, including palatable flavor, texture, and chemical perception. Moreover, transection of nerves associated with either olfaction or gustation (i.e., olfactory or glossopharyngeal nerve) has been shown to decrease fat ingestion (1) (2) (3) . In the central nervous system, several studies have suggested that the opioid system, canonically associated with reward circuitry, is associated with dietary preferences for fat. We recently reported that fat ingestion induces elevations in the endogenous opioid peptide, beta-endorphin, in cerebrospinal fluid (4) . Furthermore, we have also demonstrated that fat ingestion can activate pro-opiomelanocortin (POMC) neurons in the hypothalamus, which synthesize beta-endorphin (5) . Many reports have suggested that administration of opioid receptor antagonists can attenuate fat preference, an observation that is consistent with our findings (4, (6) (7) (8) .
A significant amount of experimental evidence implicates the opioid system in the reward and reinforcement of drug addiction. We previously demonstrated that, similar to drug administration, fat ingestion can serve as a reinforcer by inducing place preference or strong lever-pressing behavior in mice (we define these as "reinforcing effects") (9, 10) . Moreover, it has been reported that opioid receptor antagonists can diminish the reinforcing influence of fat (11) . These findings suggest that the opioid system contributes not only to fat preference, but also to reinforcement. However, the concentration of fat that produces a reinforcing effect might differ from that inducing preference behavior. Indeed, while mice prefer fat even at low concentrations (12) , the reinforcing property of fat is only observed in response to substances with higher fat content (13) . These findings indicate that the mechanisms underlying preference for fat are distinctly dependent on fat content. Since POMC neurons regulate energy homeostasis modulating feeding and/or energy expenditure (14) (15) (16) (17) , the opioid system might have an influence on the preference for high fat concentrations.
It also seems likely that several nerves (i.e., the chorda tympani, glossopharyngeal, and trigeminal nerves) are involved in recognizing the presence of dietary fat in the oral cavity. In particular, the glossopharyngeal nerve contributes to preference behavior associated with high concentrations of fat, since glossopharyngeal nerve transection (GLX) can partially inhibit POMC neurons that have been activated by fat ingestion (5) . Conversely, olfactory nerve transection (ONX) can abolish the preference for low fat concentrations (18) ; thus, olfactory and gustatory transduction related to fat preference might rely on fat concentration in a different manner.
However, few studies have examined the mechanistic differences in fat preference in relation to various fat concentrations. In order to confirm the participation of the opioid system in mediating fat preference, we examined the effect of an opioid receptor antagonist (naltrexone) on the ingestion of various concentrations of Intralipid (fat emulsion) in mice. We also investigated the effect of ONX and GLX on this ingestive behavior in order to elucidate the role of olfactory and gustatory transductions in modulating preference at varying Intralipid concentrations. Lastly, we combined an operant task under a progressive (PR) schedule with either naltrexone, ONX, or GLX to reveal the mechanisms for the reinforcing effects induced by Intralipid at high concentrations.
MATERIALS AND METHODS
Animals. Eight-week-old male BALB/c mice were obtained from Japan SLC, Inc. (Hamamatsu, Japan) for each experiment. Six mice were housed in a vivarium maintained at 2362˚C under a 12:12-h light/dark cycle (lights off 0600-1800) either together in one cage for the operant task or alone for the two-bottle choice test. Commercial standard laboratory chow (MF; Oriental Yeast, Co., Ltd., Tokyo, Japan) and water were available ad libitum. Mice were allowed to acclimate to their surroundings for at least 1 wk after their arrival, before the onset of testing. All experiments were carried out during the dark phase (0800-1600). Newly purchased mice were used for all experiments. This study was conducted in accordance with the ethical guidelines of the Kyoto University Animal Experimentation Committee, and was in complete compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The Kyoto University Animal Care and Use Committee approved all procedures used. Efforts were made to minimize the number of animals and to limit experimentation to that which was necessary to produce reliable scientific information.
Preparation of test fat emulsion. We used Intralipid (Thermo, Tokyo, Japan), which is a commercially available intravenous fat emulsion containing 20% soybean oil, 1.2% lecithin, and 2.25% glycerol. A dilution series of Intralipid (0.1, 0.3, 1.3, and 5%) was prepared using water as the diluent.
Olfactory nerve transection. Mice were anesthetized with pentobarbital (50 mg/kg) and placed in a stereotaxic instrument using ear bars and an incisor holder. We exposed the right and left olfactory bulbs by incising the skin at the midline over the anterior skull and making a hole in the bone immediately rostral to bregma. A 0.2-mm-thick small Teflon blade was inserted between the olfactory bulbs and the cribriform plate, and was run across the base of both bulbs, resulting in bilateral transection of the olfactory nerve fibers. The skin incision was then closed with a nylon suture. Sham mice received the same surgical procedure but without transection of olfactory nerve fibers. After surgery, all mice were allowed to recover for at least 5 d. At the end of the experiment, olfactory sensitivity was functionally evaluated by a potato chip finding test (1) . A 12-h fooddeprived mouse, which had already experienced the potato chip test to avoid neophobia, was placed in a test cage (182 mm3260 mm3128 mm) with flooring covered with a thin layer of nesting paper. Under the nesting material, one fragment of a potato chip was buried, and the latency to locate the potato chip was recorded. Sham mice found the potato chip within 60 s, but ONX mice were unable to find the chip. The cut-off time used as a criterion for ONX mice was 180 s, and data obtained from mice not meeting this criterion were excluded.
Glossopharyngeal nerve transection. Mice were anesthetized with pentobarbital (50 mg/kg) and the bilateral glossopharyngeal nerves, which innervate taste buds on the posterior part of the tongue, were cut in the neck under the digastric muscle. Sham control mice underwent a similar surgical operation, but both nerves were left intact. After surgery, all mice were allowed to recover for at least 5 d. At the end of the experiment, the circumvallate papillae of each mouse were removed and stained with hematoxylin and eosin for verifying the success of the surgery (5). Unlike sham mice, taste buds in the circumvallate papillae of GLX mice severely diminish (data not shown), and the data obtained from GLX mice that did not suffer a loss of taste buds in their circumvallate papillae were excluded from the study.
Two-bottle choice test procedure. In order to impart training for selection of the preferred fluid, mice were simultaneously offered a bottle containing 20% Intralipid and a bottle containing water for 10 min daily for more than 3 d. Then, mice were offered a pair of different concentrations of Intralipid and water for 10 min once per day. The test fluids were presented randomly in an attempt to avoid any effect of concentration order. Additionally, the left-right positions of the test fluids were alternated daily to avoid producing a side preference.
Effect of naltrexone on Intralipid preference in the twobottle choice test. We next examined the effect of opioid receptor antagonist naltrexone (Sigma, St. Louis, MO) on ingestive behavior. After training sessions, the twobottle choice test was conducted using water and 0.3, 1.3, 5, or 20% Intralipid 30 min after mice were subcutaneously administrated naltrexone (0.5 and 2 mg/kg) or saline.
Effect of ONX and GLX on Intralipid preference in the two-bottle choice test. Subsequently, we investigated the effect of ONX and GLX on the ingestive behavior of Intralipid in the two-bottle choice test. ONX and GLX surgeries were conducted after completion of training sessions. After a 5-d recovery period, the two-bottle choice test was conducted using water and 0.3, 1.3, 5, or 20% Intralipid. All behavioral tests were completed within 14 d after surgery.
Operant lever-press apparatus. The apparatus we employed for the operant lever-press paradigm consisted of outer chambers with a small fan for ventilation, which attenuated the surrounding sounds, and an inner chamber that we used as the operant task chamber (Med Associates, St. Albans, VT). The operant task chamber (20 cm324 cm318 cm) was made of Plexiglass and had a metal grid floor. The center of the right wall contained a liquid dipper 1 cm above the floor, a single retractable lever 6 cm to the left of the dipper and 2 cm above the floor, a light stimulus directly above the lever, and a buzzer to the right of dipper. When the mice accomplished a defined task, the light stimulus and the buzzer were operated for 1 s followed by delivery of 10 mL of the reinforcer through the dipper. A house light on the opposite wall, located 10 cm above the floor, was lit throughout the session.
Operant lever-press training. The procedure used in the current study was based on earlier reports (19, 20) and our previous study (10) , with small modifications. Briefly, mice were food-restricted for 5 d to maintain their body weight at 80-90% of their original weight. Five sessions were conducted under a fixed ratio (FR) 1 schedule by using sweetened condensed milk (Morinaga, Tokyo, Japan) as a reinforcer, which was delivered by a single-lever response. The session was conducted once a day for 30 min. Mice that did not press the lever more than 50 times for 30 min during five sessions under the FR1 schedule were excluded. Mice were then tested for two FR5 sessions and were returned to ad libitum feeding for 3 d. Mice were then presented with a PR session where the following progression of response requirements was used: 1, 2, 5, 8, 13, 18, 25, 32, 41, 50, 61, 72, 85, 98, 113, 128, 145, 162, 181, 200, etc. (n3n/2, n indicates the number of acquiring reinforcer). Each PR session ended when a mouse did not receive the reinforcer within a 15-min time limit per level. The breakpoint in a PR session was defined as the last ratio level that was completed before 15 min had elapsed without the mouse receiving a reinforcer.
The reinforcing effect of Intralipid depended on concentration. Mice that had been trained on the lever-press paradigm were used to investigate the reinforcing effect of various concentrations of Intralipid. The PR schedule was conducted in the order of low to high concentration of Intralipid (0, 0.3, 1.3, 5, and 20%) for 5 consecutive days. Since the breakpoint was unstable for several days after we changed the reinforcer, the breakpoint of the 5th session was assessed as the reinforcing effect.
Effect of naltrexone on the reinforcing effect of Intralipid. Mice trained as described above were used to investigate the effect of an opioid receptor antagonist under the PR schedule. The PR schedule was applied using water as a reinforcer once a day for 5 d (basal setting). Under the PR schedule, mice were then given 20% Intralipid as a reinforcer for 5 consecutive days under the subcutaneous administration of naltrexone (2 mg/kg) or saline 30 min before every test session. The breakpoint for Intralipid on day 5 was assessed as the reinforcing effect.
Effect of ONX and GLX on the reinforcing effect of Intralipid. Mice trained as described above were used to investigate the effect of ONX and GLX surgeries under the PR schedule. The PR schedule was applied using water as a reinforcer once a day for 5 d (basal setting). Mice were then operated on for ONX, GLX, or sham surgery. After a 5-d recovery period, PR sessions were conducted for 5 consecutive days. The breakpoint determined on day 5 was referred to as the reinforcing effect.
Statistical analyses.
All values are presented as the mean6SE. The statistical significance of Intralipid intake compared to water in the two-bottle choice test and the effect of naltrexone, ONX, and GLX on Intralipid intake and preference compared to control mice were analyzed using a two-way repeated measures analysis of variance (ANOVA) followed by Bonferroni's post hoc test. The breakpoint of fat in the operant task was analyzed using a one-way repeated measures ANOVA followed by Dunnett's post hoc test. Lastly, effects of naltrexone, ONX, and GLX on the breakpoint in the operant task were examined using the unpaired t-test (Prism 5.0; GraphPad Software, Inc., San Diego, CA).
RESULTS

Intralipid preference in relation to the concentration
We examined the preference for various concentrations of Intralipid. Mice significantly preferred 0.3, 1.3, 5, and 20% Intralipid to water in the two-bottle choice test (Fig. 1) . Furthermore, there was no significant difference in the preference for Intralipid dilutions between the dilution series with water as the diluent and that with water containing 1.2% lecithin, 2.25% glycerol, and small quantities of sodium hydroxide for pH control (data not shown). We used the dilution series of Intralipid prepared using water as the diluent in the following experiments.
Effect of naltrexone on Intralipid preference
We administered naltrexone in order to investigate the involvement of the opioid system on determining preference of several Intralipid concentrations. We found that mice preferred 0.3, 1.3, 5, and 20% Intralipid to water even after naltrexone administration ( Fig. 2A, B,  C) . Additionally, there were no significant differences in Intralipid preference between groups (Fig. 2E) . However, administration of naltrexone significantly decreased the intake of Intralipid at 5 and 20% concentrations (Fig. 2D) . We also examined the effect of naltrexone on spontaneous motor activity and found that naltrexone administration did not alter spontaneous motor activity in mice (data not shown). Therefore, it appears that nonspecific effects of naltrexone had little to no impact on our results. 
Effect of ONX on Intralipid preference
We used ONX mice in order to investigate the role of the olfactory nerve in establishing preference to several concentrations of Intralipid, and found that the preference for 0.3 and 1.3% Intralipid was abolished by ONX surgery (Fig. 3A, B) . Moreover, overall Intralipid intake and preference in ONX mice were significantly lower than in sham mice for 1.3, 5, and 20% concentrations of Intralipid (Fig. 3C, D) .
Effect of GLX on Intralipid preference
We used GLX mice in order to investigate the contribution of the glossopharyngeal nerve in establishing preference to several Intralipid concentrations, and found that mice preferred 0.3, 1.3, 5, and 20% Intralipid to water even after GLX surgery (Fig. 4A, B) . Additionally, we determined that there were no significant differences of Intralipid preference between groups (Fig. 4D) . However, Intralipid intake of GLX mice was significantly lower at 1.3 and 5% Intralipid concentrations (Fig. 4C) .
The reinforcing effect of Intralipid in relation to the concentration
We also examined the reinforcing effect of various concentrations of Intralipid. Mice exhibited reinforcement of Intralipid over water only at the 20% Intralipid concentration (Fig. 5) .
Effect of naltrexone, ONX, and GLX on the reinforcing effect of Intralipid
We used the opioid receptor antagonist, naltrexone, to evaluate the role of the opioid system in establishing the reinforcing effect of Intralipid, and found that naltrexone significantly decreased the reinforcing effect of 20% Intralipid (Fig. 6A, B) . We also investigated whether the olfactory and glossopharyngeal nerves contributed to the reinforcing effect of Intralipid by using ONX and GLX mice, and found that the reinforcing effects of 20% Intralipid in ONX and GLX mice were significantly lower than in sham mice (Fig. 6C-F) .
DISCUSSION
In this study, we examined the effects of naltrexone administration, ONX, and GLX on the preference for various Intralipid concentrations and on the reinforcing effects of Intralipid at high concentrations. We found that Intralipid intake was reduced by naltrexone administration, ONX, and GLX. However, the effect of naltrexone was only observed at higher concentrations of Intralipid. And the effects of ONX and GLX on Intralipid were mainly observed at lower concentrations of Intralipid. Furthermore, the reinforcing effect of Intralipid during an operant task was attenuated by naltrexone, ONX, and GLX.
High concentrations of dietary fat are both reinforcing and palatable in mice, but other palatable foods are not always reinforcing. We previously reported that sorbitol fatty acid ester (a nondigestible fat substitute) and low concentrations of fatty acids elicit preference behaviors, but not reinforcing effects, in mice (13, 21) . However, we could observe reinforcement for sorbitol fatty acid ester and low concentrations of fatty acid when mice were administered energy substrates intragastrically. On the other hand, mice preferred mineral oil but did not display reinforcing behavior even after intragastric administration of energy substrates (13, 22, 23) . Collectively, these results suggest that the high-energy content and palatability of mineral oil does not seem to be an essential factor in producing a reinforcing effect. In our current study, the reinforcing effect of Intralipid was only observed at the highest Intralipid concentration we tested (20%) while a preference for Intralipid was observed at Intralipid concentrations of 0.3% and higher (Figs. 1 and 5 ). In the light of these findings, the mechanism underlying the preference for low Intralipid concentrations appears to be different from that for high Intralipid concentrations.
Since the opioid system is involved in producing a reinforcing effect in response to high fat foods, it is likely that the opioid system also plays a part in inducing a preference for high fat content. In this study, 5 and 20% Intralipid intake was reduced by naltrexone administration (Fig. 2) . These results support a role for the opioid system in generating preference for high levels of dietary fat. Moreover, this role is consistent with the fact that POMC neurons and the opioid system are involved in the regulation of energy homeostasis (14) (15) (16) (17) . The POMC neuron can be activated by ingestion of fat but cannot be sufficiently activated by intragastric administration of fat (5) . It has also been reported that naltrexone administration can reduce sucrose intake even in animals that have been esophagostomized to prevent post-ingestive effects (24) . Therefore, it is possible that the opioid system is activated by the oral perception of high fat concentrations (which contributes to palatability) and that this activation simultaneously regulates energy homeostasis.
In the current study, we found that, like naltrexone administration, ONX and GLX could also reduce the Intralipid intake. Moreover, the effect of ONX and GLX was stronger at lower Intralipid concentrations (Figs. 3  and 4) . Thus, the olfactory and glossopharyngeal nerves are more involved in mediating preference behavior to substances with low Intralipid concentrations (less than 5% Intralipid). This is consistent with previous reports on the slight effect of GLX on POMC activation during high fat ingestion (5, 25) . Additionally, several studies have demonstrated that naltrexone administration does not affect the preference for a flavor that has been "acquired by experience" (26) (27) (28) . Moreover, the current study demonstrated that the effect of naltrexone, ONX, and GLX were all distinctly dependent on Intralipid concentration (Figs. 2, 3 and 4) . Therefore, there might be different preference mechanisms depending on the level of Intralipid encountered. In this study, Intralipid preference was not affected by naltrexone or GLX since water intake was very little (Figs. 2 and 4) . Thus, our interpretation was that Intralipid intake was more reflective of Intralipid palatability than Intralipid preference ratio.
Although the role of the opioid system in mediating the reinforcing effect of fat is known, the roles of olfactory and glossopharyngeal nerve transduction in fat reinforcement have not been elucidated (11, 19) . Therefore, we also examined the effect of naltrexone, ONX, and GLX on the reinforcing effect of high Intralipid concentrations. Consistent with previous reports, the reinforcing effect of high Intralipid was suppressed by naltrexone administration even when assessing reinforcement by different methods (conditioned place preference test) (11) . Interestingly, we found that both the olfactory and glossopharyngeal nerves were similar to the opioid system in their response to Intralipid since naltrexone, ONX, and GLX attenuated the reinforcing effect of a high concentration of Intralipid. In our results, the breakpoint of ONX-sham mice was lower than that of unaltered mice (Figs. 5 and 6 ). Since ONXsham mice also exhibited slightly lower levels of spontaneous motor activity than unaltered mice (data not shown), such a nonspecific effect might influence the results of the current experiment. However, there was no significant difference in body weight or spontaneous motor activity between ONX-sham and ONX mice (data not shown). Therefore, the difference in breakpoint between ONX-sham and ONX mice may be the result of an olfactory dysfunction in ONX mice. In addition, there have been many reports implicating the involvement of the olfactory system in the preference for dietary fat (3, 18, (29) (30) (31) . Moreover, the effect of ONX on fat preference is reportedly stronger in dietary items with low fat content that are poor in nutritive value (1). Additionally, the preference for low Intralipid concentrations (0.3% Intralipid) was not observed in naïve mice (data not shown). Thus, olfactory nerve transduction may be involved in the reinforcing effect via a learning process for fat preference.
In esophagostomized rats, oral stimulation with longchain fatty acids has been shown to enhance pancreatic enzyme secretion (32) . This report suggests that the gustatory system can recognize fatty acids as nutritive and can initiate appropriate metabolic responses. It has also been previously shown that CD36, GPR120, and GPR40, also known as fatty acid-binding proteins, are expressed in circumvallate papillae innervated by the glossopharyngeal nerve (33, 34) . Moreover, mice deficient in these fatty acid-binding proteins exhibit a reduced appetite for long-chain fatty acids (35) (36) (37) . The glossopharyngeal nerve also plays an important part in lingual lipase secretion, which is required for the oral perception of fat (38, 39) . Therefore, the glossopharyngeal nerve may be involved in the reinforcing effect by way of signal transduction of fat molecules from the oral cavity. In this study, we did not investigate the involvement of the other nerves that innervate the oral cavity, such as the chorda tympani and trigeminal nerves. However, as dietary fat stimulates or modulates the response of both of these nerves, they may also be involved in fat palatability and the reinforcing effect (40, 41) .
The results of our current study demonstrate that 0.3-5% Intralipid did not produce a reinforcing effect (Fig. 5) , indicating that olfactory and glossopharyngeal nerve transduction might not be sufficient to induce reinforcement but that the opioid system is necessary for this behavior. However, ONX, GLX, and naltrexone were all effective in attenuating the reinforcing effect of high Intralipid. This indicates that high Intralipid preference initiated by the olfactory and glossopharyngeal nerves may be accompanied by activation of the opioid system. Further studies are therefore needed to elucidate the mechanism of opioid system activation induced by dietary fat ingestion. Lastly, although it has been reported that the opioid system is related to satiety, the effects of naltrexone, ONX, and GLX on satiety under our experimental conditions are unclear (42) . We would like to consider this issue in future experiments.
In conclusion, the current study demonstrates that the opioid system, olfactory nerve, and glossopharyngeal nerve participate in producing the preference and reinforcing effects of Intralipid. Our results also indicate that the mechanism for Intralipid preference is partly dependent on the Intralipid concentration. Specifically, we found that the opioid system greatly contributed to the preference for high concentrations of Intralipid, while olfactory and glossopharyngeal nerve transductions seemed to be involved in the palatability that low Intralipid contributes.
